{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:29:05Z","timestamp":1760149745645,"version":"build-2065373602"},"reference-count":128,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Steven &amp; Alexandra Cohen Foundation"},{"name":"Lyme and Tick-Borne Diseases Research Center"},{"name":"Columbia University Vagelos College of Physicians and Surgeons"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Lyme disease, the most common tick-borne disease in the United States, is caused by infection with the spirochete Borrelia burgdorferi. While most patients with acute Lyme disease recover completely if treated with antibiotics shortly after the onset of infection, approximately 10\u201330% experience post-treatment symptoms and 5\u201310% have residual symptoms with functional impairment (post-treatment Lyme disease syndrome or PTLDS). These patients typically experience pain, cognitive problems, and\/or fatigue. This narrative review provides a broad overview of Lyme disease, focusing on neuropsychiatric manifestations and persistent symptoms. While the etiology of persistent symptoms remains incompletely understood, potential explanations include persistent infection, altered neural activation, and immune dysregulation. Widely recognized is that new treatment options are needed for people who have symptoms that persist despite prior antibiotic therapy. After a brief discussion of treatment approaches, the article focuses on vagus nerve stimulation (VNS), a neuromodulation approach that is FDA-approved for depression, epilepsy, and headache syndromes and has been reported to be helpful for other diseases characterized by inflammation and neural dysregulation. Transcutaneous VNS stimulates the external branch of the vagus nerve, is minimally invasive, and is well-tolerated in other conditions with few side effects. If well-controlled double-blinded studies demonstrate that transcutaneous auricular VNS helps patients with chronic syndromes such as persistent symptoms after Lyme disease, taVNS will be a welcome addition to the treatment options for these patients.<\/jats:p>","DOI":"10.3390\/antibiotics12091347","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T08:58:54Z","timestamp":1692694734000},"page":"1347","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuropsychiatric Lyme Disease and Vagus Nerve Stimulation"],"prefix":"10.3390","volume":"12","author":[{"given":"Nicholas","family":"Biniaz-Harris","sequence":"first","affiliation":[{"name":"Lyme & Tick-Borne Diseases Research Center at Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY 10032, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7684-6219","authenticated-orcid":false,"given":"Mara","family":"Kuvaldina","sequence":"additional","affiliation":[{"name":"Lyme & Tick-Borne Diseases Research Center at Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY 10032, USA"},{"name":"Department of Psychiatry, Columbia University Irving Medical Center, New York, NY 10032, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4899-1697","authenticated-orcid":false,"given":"Brian A.","family":"Fallon","sequence":"additional","affiliation":[{"name":"Lyme & Tick-Borne Diseases Research Center at Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY 10032, USA"},{"name":"Department of Psychiatry, Columbia University Irving Medical Center, New York, NY 10032, USA"},{"name":"New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"key":"ref_1","unstructured":"(2023, June 15). Surveillance Data|Lyme Disease|CDC. 27 October 2022, Available online: https:\/\/www.cdc.gov\/lyme\/datasurveillance\/surveillance-data.html."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3201\/eid2702.202731","article-title":"Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010\u20132018","volume":"27","author":"Kugeler","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3201\/eid2702.202728","article-title":"Use of Commercial Claims Data for Evaluating Trends in Lyme Disease Diagnoses, United States, 2010\u20132018","volume":"27","author":"Schwartz","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJM200306123482423","article-title":"The presenting manifestations of Lyme disease and the outcomes of treatment","volume":"348","author":"Steere","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/cid\/cix568","article-title":"Characteristics and Clinical Outcome of Lyme Neuroborreliosis in a High Endemic Area, 1995-2014: A Retrospective Cohort Study in Denmark","volume":"65","author":"Knudtzen","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1212\/WNL.45.11.2010","article-title":"Detection of Borrelia burgdorferi-specific antigen in antibody-negative cerebrospinal fluid in neurologic Lyme disease","volume":"45","author":"Coyle","year":"1995","journal-title":"Neurology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1086\/649920","article-title":"Antibiotic treatment duration and long-term outcomes of patients with early lyme disease from a lyme disease-hyperendemic area","volume":"50","author":"Kowalski","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fmed.2020.00057","article-title":"Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease","volume":"7","author":"Rebman","year":"2020","journal-title":"Front. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijid.2022.01.033","article-title":"Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: A prospective cohort study","volume":"116","author":"Aucott","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11136-012-0126-6","article-title":"Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: Is there something here?","volume":"22","author":"Aucott","year":"2013","journal-title":"Qual. Life Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/arclin\/acy051","article-title":"Cognitive Decline in Post-treatment Lyme Disease Syndrome","volume":"34","author":"Touradji","year":"2019","journal-title":"Arch. Clin. Neuropsychol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.42.7.1263","article-title":"Memory impairment and depression in patients with Lyme encephalopathy: Comparison with fibromyalgia and nonpsychotically depressed patients","volume":"42","author":"Kaplan","year":"1992","journal-title":"Neurology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S1355617706060231","article-title":"WAIS-III and WMS-III performance in chronic Lyme disease","volume":"12","author":"Keilp","year":"2006","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1020381913563","article-title":"Neuropsychological functioning in chronic Lyme disease","volume":"12","author":"Westervelt","year":"2002","journal-title":"Neuropsychol. Rev."},{"key":"ref_16","first-page":"282","article-title":"Memory functioning in Lyme borreliosis","volume":"57","author":"Ravdin","year":"1996","journal-title":"J. Clin. Psychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.4045\/tidsskr.11.0683","article-title":"A Woman in her 50s with manic psychosis","volume":"132","author":"Pasareanu","year":"2012","journal-title":"Tidsskr. Den Nor. Legeforening"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0006-3223(98)00277-7","article-title":"Borrelia burgdorferi central nervous system infection presenting as an organic schizophrenialike disorder","volume":"45","author":"Hess","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/art.24314","article-title":"Role of psychiatric comorbidity in chronic lyme disease","volume":"59","author":"Hassett","year":"2008","journal-title":"Arthritis Care Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Bransfield, R.C. (2018). Neuropsychiatric Lyme Borreliosis: An Overview with a Focus on a Specialty Psychiatrist\u2019s Clinical Practice. Healthcare, 6.","DOI":"10.3390\/healthcare6030104"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.psym.2018.02.004","article-title":"Depressive Symptoms and Suicidal Ideation Among Symptomatic Patients With a History of Lyme Disease vs Two Comparison Groups","volume":"59","author":"Doshi","year":"2018","journal-title":"Psychosomatics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jamapsychiatry.2020.2915","article-title":"Assessment of the Risk of Psychiatric Disorders, Use of Psychiatric Hospitals, and Receipt of Psychiatric Medication among Patients with Lyme Neuroborreliosis in Denmark","volume":"78","author":"Tetens","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1176\/appi.ajp.2021.20091347","article-title":"Lyme Borreliosis and Associations With Mental Disorders and Suicidal Behavior: A Nationwide Danish Cohort Study","volume":"178","author":"Fallon","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1749-6632.1988.tb31835.x","article-title":"Nervous system abnormalities in Lyme disease","volume":"539","author":"Halperin","year":"1988","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/02841850701367903","article-title":"Brain magnetic resonance imaging does not contribute to the diagnosis of chronic neuroborreliosis","volume":"48","author":"Aalto","year":"2007","journal-title":"Acta Radiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1086\/516175","article-title":"Functional brain imaging and neuropsychological testing in Lyme disease","volume":"25","author":"Fallon","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1097\/RLU.0b013e318262ad9b","article-title":"SPECT brain imaging in chronic Lyme disease","volume":"37","author":"Donta","year":"2012","journal-title":"Clin. Nucl. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1212\/WNL.49.6.1661","article-title":"Reversible cerebral hypoperfusion in Lyme encephalopathy","volume":"49","author":"Logigian","year":"1997","journal-title":"Neurology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archgenpsychiatry.2009.29","article-title":"Regional cerebral blood flow and metabolic rate in persistent Lyme encephalopathy","volume":"66","author":"Fallon","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12974-018-1381-4","article-title":"Imaging glial activation in patients with post-treatment Lyme disease symptoms: A pilot study using [11 C]DPA-713 PET","volume":"15","author":"Coughlin","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1128\/AAC.01050-07","article-title":"Persistence of Borrelia burgdorferi following Antibiotic Treatment in Mice","volume":"52","author":"Hodzic","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Embers, M.E., Barthold, S.W., Borda, J.T., Bowers, L., Doyle, L., Hodzic, E., Jacobs, M.B., Hasenkampf, N.R., Martin, D.S., and Narasimhan, S. (2012). Persistence of Borrelia burgdorferi in Rhesus Macaques following Antibiotic Treatment of Disseminated Infection. PLoS ONE, 7.","DOI":"10.1371\/annotation\/4cafed66-fb84-4589-a001-131d9c50aea6"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1086\/648091","article-title":"Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than borrelia afzelii or borrelia garinii","volume":"200","author":"Strle","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"628045","DOI":"10.3389\/fneur.2021.628045","article-title":"Detecting Borrelia Spirochetes: A Case Study With Validation Among Autopsy Specimens","volume":"12","author":"Gadila","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_35","first-page":"61","article-title":"Lyme Disease and clinical spectrum of antibiotic responsive chronic meningoencephalomyelitis","volume":"4","author":"Liegner","year":"1997","journal-title":"J. Spirochetal Tick Borne Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1212\/WNL.42.1.43","article-title":"Neuroactive kynurenines in Lyme borreliosis","volume":"42","author":"Halperin","year":"1992","journal-title":"Neurology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000086441","article-title":"Gabapentin for the Symptomatic Treatment of Chronic Neuropathic Pain in Patients with Late-Stage Lyme Borreliosis: A Pilot Study|Dermatology|Karger Publishers","volume":"211","author":"Weissenbacher","year":"2005","journal-title":"Dermatology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/IMCRJ.S137975","article-title":"Effects of intravenous ketamine in a patient with post-treatment Lyme disease syndrome","volume":"10","author":"Hanna","year":"2017","journal-title":"Int. Med. Case Rep. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jpain.2015.08.004","article-title":"Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-blind, Placebo-controlled Trial","volume":"16","author":"Natelson","year":"2015","journal-title":"J. Pain"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12974-022-02681-x","article-title":"The FGF\/FGFR system in the microglial neuroinflammation with Borrelia burgdorferi: Likely intersectionality with other neurological conditions","volume":"20","author":"Parthasarathy","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10286-021-00798-2","article-title":"Long-COVID postural tachycardia syndrome: An American Autonomic Society statement","volume":"31","author":"Raj","year":"2021","journal-title":"Clin. Auton. Res."},{"key":"ref_42","first-page":"63","article-title":"Postural orthostatic tachycardia syndrome following Lyme disease","volume":"18","author":"Kanjwal","year":"2011","journal-title":"Cardiol. J."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Novak, P., Felsenstein, D., Mao, C., Octavien, N.R., and Zubcevik, N. (2019). Association of small fiber neuropathy and post treatment Lyme disease syndrome. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0212222"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1128\/iai.62.10.4632-4636.1994","article-title":"Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: Dependence on lipid modification","volume":"62","author":"Weis","year":"1994","journal-title":"Infect. Immun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"13498","DOI":"10.1073\/pnas.1904170116","article-title":"Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis","volume":"116","author":"Jutras","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2012.10.011","article-title":"Increased IFN\u03b1 activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits","volume":"255","author":"Jacek","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cid\/cit735","article-title":"Elevated Levels of IL-23 in a Subset of Patients With Post-Lyme Disease Symptoms Following Erythema Migrans","volume":"58","author":"Strle","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/CVI.00071-16","article-title":"CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: A Prospective Clinical Cohort Study","volume":"23","author":"Aucott","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Soloski, M.J., Crowder, L.A., Lahey, L.J., Wagner, C.A., Robinson, W.H., and Aucott, J.N. (2014). Serum inflammatory mediators as markers of human Lyme disease activity. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0093243"},{"key":"ref_50","first-page":"1091","article-title":"Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-\u03b1 in Blood","volume":"29","author":"Ogrinc","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1128\/iai.63.10.4130-4137.1995","article-title":"Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides","volume":"63","author":"Seidman","year":"1995","journal-title":"Infect. Immun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.bbi.2010.03.002","article-title":"Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms","volume":"24","author":"Chandra","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/infdis\/167.6.1372","article-title":"Cross-reactivity between Borrelia burgdorferi flagellin and a human axonal 64,000 molecular weight protein","volume":"167","author":"Sigal","year":"1993","journal-title":"J. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev.immunol.15.1.63","article-title":"Lyme disease: A review of aspects of its immunology and immunopathogenesis","volume":"15","author":"Sigal","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.38.9.1439","article-title":"Lyme disease patients\u2019 serum contains IgM antibodies to Borrelia burgdorferi that cross-react with neuronal antigens","volume":"38","author":"Sigal","year":"1988","journal-title":"Neurology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jneuroim.2004.10.014","article-title":"Antibodies against OspA epitopes of Borrelia burgdorferi cross-react with neural tissue","volume":"159","author":"Alaedini","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"100015","DOI":"10.1016\/j.bbih.2019.100015","article-title":"Anti-lysoganglioside and other anti-neuronal autoantibodies in post-treatment Lyme Disease and Erythema Migrans after repeat infection","volume":"2","author":"Fallon","year":"2020","journal-title":"Brain Behav. Immun.-Health"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/acr.24495","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease","volume":"73","author":"Lantos","year":"2021","journal-title":"Arthritis Care Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","article-title":"Study and treatment of post Lyme disease (STOP-LD): A randomized double masked clinical trial","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","article-title":"A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy","volume":"70","author":"Fallon","year":"2008","journal-title":"Neurology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/1874205X01206010079","article-title":"A Reappraisal of the U.S. Clinical Trials of Post-Treatment Lyme Disease Syndrome","volume":"6","author":"Fallon","year":"2012","journal-title":"Open Neurol. J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1113\/EP090802","article-title":"Long COVID: Mechanisms, risk factors and recovery","volume":"108","author":"Astin","year":"2023","journal-title":"Exp. Physiol."},{"key":"ref_64","unstructured":"Katz, A., and Berkley, J. (May, January 25). Diminished Epidermal Nerve Fiber Density in Patients with Antibodies to Outer Surface Protein A (OspA) of B. burgdorferi Improves with Intravenous Immunoglobulin Therapy. Proceedings of the American Academy of Neurology Annual Meeting, Seattle, WA, USA. Available online: https:\/\/www.researchgate.net\/publication\/291971596_Diminished_Epidermal_Nerve_Fiber_Density_in_Pa-tients_with_Antibodies_to_Outer_Surface_Protein_A_OspA_of_B_burgdorferi_Improves_with_Intravenous_Immunoglobulin_Therapy_Katz_A_Berkley_JM_Neurology_20097."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1086\/515145","article-title":"Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis","volume":"28","author":"Dotevall","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"ref_66","first-page":"1338","article-title":"Lyme disease: A multisystem infection that affects the nervous system","volume":"18","author":"Halperin","year":"2012","journal-title":"Continuum"},{"key":"ref_67","first-page":"1040","article-title":"Neurologic Complications of Lyme Disease","volume":"27","author":"Roos","year":"2021","journal-title":"Continuum"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/IDR.S66739","article-title":"Chronic Lyme disease: Misconceptions and challenges for patient management","volume":"8","author":"Halperin","year":"2015","journal-title":"Infect. Drug Resist."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Lu, Y., and Zand, R. (2022). Characteristics of Lyme optic neuritis: A case report of Lyme associated bilateral optic neuritis and systematic review of the literature. BMC Neurol., 22.","DOI":"10.1186\/s12883-022-02627-z"},{"key":"ref_70","first-page":"83","article-title":"A Case of Optic Neuritis Secondary to Lyme Disease","volume":"117","author":"Jha","year":"2018","journal-title":"WMJ"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ejpn.2016.05.022","article-title":"Acute isolated partial oculomotor nerve palsy due to Lyme neuroborreliosis in a 5 year old girl","volume":"20","author":"Drenckhahn","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s002340050382","article-title":"Isolated oculomotor nerve paralysis in Lyme disease: MRI","volume":"39","author":"Savas","year":"1997","journal-title":"Neuroradiology"},{"key":"ref_73","first-page":"9720843","article-title":"Diplopia: A Rare Manifestation of Neuroborreliosis","volume":"2018","author":"Dixit","year":"2018","journal-title":"Case Rep. Neurol. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10792-011-9482-4","article-title":"Isolated trochlear palsy secondary to Lyme neuroborreliosis","volume":"31","author":"Bababeygy","year":"2011","journal-title":"Int. Ophthalmol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1090-3798(98)80042-1","article-title":"Neuroborreliosis and isolated trochlear palsy","volume":"2","author":"Neubauer","year":"1998","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0002-9394(89)90856-8","article-title":"Ocular Lyme borreliosis","volume":"108","author":"Winward","year":"1989","journal-title":"Am. J. Ophthalmol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3928\/01913913-20090616-17","article-title":"Self-limiting fourth and sixth cranial nerve palsy after Lyme disease","volume":"47","author":"Sharma","year":"2010","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejpn.2007.11.009","article-title":"Lyme disease with lymphocytic meningitis, trigeminal palsy and silent thalamic lesion","volume":"12","author":"Freitag","year":"2008","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/head.13220","article-title":"Lyme Disease Presenting With Raeder Syndrome","volume":"58","author":"Budhram","year":"2018","journal-title":"Headache"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/WNO.0b013e318064e4ba","article-title":"Lyme disease associated with postganglionic Horner syndrome and Raeder paratrigeminal neuralgia","volume":"27","author":"Murphy","year":"2007","journal-title":"J. Neuroophthalmol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/OPX.0000000000001861","article-title":"Case Report: An Isolated Abducens Palsy Secondary to Lyme Disease","volume":"99","author":"Mashburn","year":"2022","journal-title":"Optom. Vis. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00041327-199403000-00002","article-title":"Isolated fascicular abducens nerve palsy and Lyme disease","volume":"14","author":"Mastrianni","year":"1994","journal-title":"J. Neuroophthalmol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e231889","DOI":"10.1136\/bcr-2019-231889","article-title":"Lyme disease with erythema migrans presenting concurrently with optic nerve perineuritis and abducens nerve palsy","volume":"13","author":"Lundin","year":"2020","journal-title":"BMJ Case Rep."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00234-002-0904-x","article-title":"Simultaneous involvement of third and sixth cranial nerve in a patient with Lyme disease","volume":"45","author":"Lell","year":"2003","journal-title":"Neuroradiology"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Sowula, K., Szaleniec, J., Dworak, M., Przeklasa, M., Maraj, M., Ceranowicz, P., and Tomik, J. (2021). Vertigo as One of the Symptoms of Lyme Disease. J. Clin. Med., 10.","DOI":"10.3390\/jcm10132814"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Sowula, K., Szaleniec, J., Stolcman, K., Ceranowicz, P., Koco\u0144, S., and Tomik, J. (2021). Association between Sudden Sensorineural Hearing Loss and Lyme Disease. J. Clin. Med., 10.","DOI":"10.3390\/jcm10051130"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1258\/shorts.2010.010080","article-title":"A case of Lyme neuroborreliosis with bilateral recurrent laryngeal nerve palsy","volume":"1","author":"Furtner","year":"2010","journal-title":"JRSM Short. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1378\/chest.14-0515","article-title":"Bilateral vocal cord paralysis requiring tracheostomy due to neuroborreliosis","volume":"146","author":"Greenberg","year":"2014","journal-title":"Chest"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4330\/wjc.v6.i6.502","article-title":"Respiratory modulation of cardiac vagal tone in Lyme disease","volume":"6","author":"Puri","year":"2014","journal-title":"World J. Cardiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000115501","article-title":"Multifocal neuropathy and vocal cord paralysis in relapsing fever","volume":"21","author":"Olchovsky","year":"1982","journal-title":"Eur. Neurol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.anpedi.2013.11.012","article-title":"Probable neuroborreliosis con par\u00e1lisis de los nervios hipogloso y vago","volume":"81","year":"2014","journal-title":"An. Pediatr."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"G1201","DOI":"10.1152\/ajpgi.00309.2006","article-title":"Spatial organization of neurons in the dorsal motor nucleus of the vagus synapsing with intragastric cholinergic and nitric oxide\/VIP neurons in the rat","volume":"294","author":"Zhou","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1152\/jn.00039.2019","article-title":"GABAA receptor currents in the dorsal motor nucleus of the vagus in females: Influence of ovarian cycle and 5\u03b1-reductase inhibition","volume":"122","author":"Littlejohn","year":"2019","journal-title":"J. Neurophysiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1007\/s00415-022-10967-6","article-title":"Efficacy and safety of VNS therapy or continued medication management for treatment of adults with drug-resistant epilepsy: Systematic review and meta-analysis","volume":"269","author":"Batson","year":"2022","journal-title":"J. Neurol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"152156","DOI":"10.1016\/j.comppsych.2019.152156","article-title":"Vagus nerve stimulation (VNS) therapy in patients with treatment resistant depression: A systematic review and meta-analysis","volume":"98","author":"Bottomley","year":"2019","journal-title":"Compr. Psychiatry"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s003810050021","article-title":"Transcutaneous vagus nerve stimulation for partial onset seizure therapy. A new concept","volume":"16","author":"Ventureyra","year":"2000","journal-title":"Childs Nerv. Syst."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/ner.12541","article-title":"Optimization of Transcutaneous Vagus Nerve Stimulation Using Functional MRI","volume":"20","author":"Yakunina","year":"2017","journal-title":"Neuromodulation"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00702-007-0755-z","article-title":"BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation","volume":"114","author":"Kraus","year":"2007","journal-title":"J. Neural Transm."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.brs.2013.01.011","article-title":"CNS BOLD fMRI effects of sham-controlled transcutaneous electrical nerve stimulation in the left outer auditory canal\u2014A pilot study","volume":"6","author":"Kraus","year":"2013","journal-title":"Brain Stimul."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1515\/BMT.2008.022","article-title":"A novel transcutaneous vagus nerve stimulation leads to brainstem and cerebral activations measured by functional MRI","volume":"53","author":"Dietrich","year":"2008","journal-title":"Biomed. Tech."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.brs.2014.11.018","article-title":"Non-invasive Access to the Vagus Nerve Central Projections via Electrical Stimulation of the External Ear: fMRI Evidence in Humans","volume":"8","author":"Frangos","year":"2015","journal-title":"Brain Stimul."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"664740","DOI":"10.3389\/fnins.2021.664740","article-title":"Auricular Vagus Neuromodulation\u2014A Systematic Review on Quality of Evidence and Clinical Effects","volume":"15","author":"Verma","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.brs.2018.08.010","article-title":"Safety and tolerability of Transcutaneous Vagus Nerve stimulation in humans; a systematic review","volume":"11","author":"Redgrave","year":"2018","journal-title":"Brain Stimul."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s42234-022-00094-y","article-title":"A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular vagus nerve stimulation (taVNS) to manage long COVID symptoms","volume":"8","author":"Badran","year":"2022","journal-title":"Bioelectron. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nature01321","article-title":"The inflammatory reflex","volume":"420","author":"Tracey","year":"2002","journal-title":"Nature"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrendo.2012.189","article-title":"The vagus nerve and the inflammatory reflex\u2014Linking immunity and metabolism","volume":"8","author":"Pavlov","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/35013070","article-title":"Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin","volume":"405","author":"Borovikova","year":"2000","journal-title":"Nature"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brs.2018.10.005","article-title":"Modulation of neuroinflammation and memory dysfunction using percutaneous vagus nerve stimulation in mice","volume":"12","author":"Huffman","year":"2019","journal-title":"Brain Stimul."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Go, Y.-Y., Ju, W.-M., Lee, C.-M., Chae, S.-W., and Song, J.-J. (2022). Different Transcutaneous Auricular Vagus Nerve Stimulation Parameters Modulate the Anti-Inflammatory Effects on Lipopolysaccharide-Induced Acute Inflammation in Mice. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020247"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41586-022-05161-7","article-title":"Brainstem ADCYAP1+ neurons control multiple aspects of sickness behaviour","volume":"609","author":"Ilanges","year":"2022","journal-title":"Nature"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"930287","DOI":"10.3389\/fimmu.2022.930287","article-title":"Sciatic-Vagal Nerve Stimulation by Electroacupuncture Alleviates Inflammatory Arthritis in Lyme Disease-Susceptible C3H Mice","volume":"13","author":"Akoolo","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.1073\/pnas.1605635113","article-title":"Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis","volume":"113","author":"Koopman","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/03009742.2020.1764617","article-title":"Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: Results of a pilot study","volume":"50","author":"Drewes","year":"2021","journal-title":"Scand. J. Rheumatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/annrheumdis-2020-217872","article-title":"Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: A randomised, double-blind, sham-controlled pilot trial","volume":"80","author":"Aranow","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3389\/fnins.2019.00854","article-title":"Current Directions in the Auricular Vagus Nerve Stimulation I\u2014A Physiological Perspective","volume":"13","author":"Kaniusas","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0193-953X(05)70196-9","article-title":"Vagus nerve stimulation. A potential therapy for resistant depression?","volume":"23","author":"George","year":"2000","journal-title":"Psychiatr. Clin. N. Am."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/ner.13528","article-title":"A Comprehensive Review of Vagus Nerve Stimulation for Depression","volume":"25","author":"Austelle","year":"2022","journal-title":"Neuromodulation"},{"key":"ref_118","first-page":"17","article-title":"A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression","volume":"6","author":"Berry","year":"2013","journal-title":"Med. Devices"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neubiorev.2015.06.019","article-title":"The antidepressant mechanism of action of vagus nerve stimulation: Evidence from preclinical studies","volume":"56","author":"Grimonprez","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.neubiorev.2005.01.004","article-title":"Vagal nerve stimulation: A review of its applications and potential mechanisms that mediate its clinical effects","volume":"29","author":"Groves","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neurom.2022.08.461","article-title":"The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue in Participants With Primary Sj\u00f6gren\u2019s Syndrome","volume":"26","author":"Tarn","year":"2023","journal-title":"Neuromodulation"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"119805","DOI":"10.1016\/j.lfs.2021.119805","article-title":"Vagal nerve stimulation as a possible non-invasive treatment for chronic widespread pain in Gulf Veterans with Gulf War Illness","volume":"282","author":"Natelson","year":"2021","journal-title":"Life Sci."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Natelson, B.H., Blate, M., and Soto, T. (2022). Transcutaneous Vagus Nerve Stimulation in the Treatment of Long Covid-Chronic Fatigue Syndrome. medRxiv.","DOI":"10.1101\/2022.11.08.22281807"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/ar.23391","article-title":"Myelinated Axons in the Auricular Branch of the Human Vagus Nerve","volume":"299","author":"Safi","year":"2016","journal-title":"Anat. Rec."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.brs.2018.03.018","article-title":"Transcutaneous nerve stimulation via the tragus: Are we really stimulating the vagus nerve?","volume":"11","author":"Burger","year":"2018","journal-title":"Brain Stimul."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"22780","DOI":"10.1038\/s41598-021-02307-x","article-title":"Human intracranial recordings reveal distinct cortical activity patterns during invasive and non-invasive vagus nerve stimulation","volume":"11","author":"Schuerman","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"709436","DOI":"10.3389\/fnins.2021.709436","article-title":"A Review of Parameter Settings for Invasive and Non-invasive Vagus Nerve Stimulation (VNS) Applied in Neurological and Psychiatric Disorders","volume":"15","author":"Thompson","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"699473","DOI":"10.3389\/fnhum.2021.699473","article-title":"Transcranial Auricular Vagus Nerve Stimulation (taVNS) and Ear-EEG: Potential for Closed-Loop Portable Non-invasive Brain Stimulation","volume":"15","author":"Ruhnau","year":"2021","journal-title":"Front. Human Neurosci."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/9\/1347\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:39:22Z","timestamp":1760128762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/9\/1347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":128,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["antibiotics12091347"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics12091347","relation":{},"ISSN":["2079-6382"],"issn-type":[{"type":"electronic","value":"2079-6382"}],"subject":[],"published":{"date-parts":[[2023,8,22]]}}}